Boston Trust Walden Corp Has $81.55 Million Stake in Dolby Laboratories $DLB

Key Points

• Boston Trust Walden Corp increased its stake in Dolby Laboratories by 2.1% in Q2, owning 1,098,218 shares valued at approximately $81.55 million.
• Dolby Laboratories reported earnings per share of $0.78 for the latest quarter, surpassing analyst expectations by $0.06, and its revenue increased by 9.2% year-over-year.
• The company declared a quarterly dividend of $0.33 per share, translating to an annualized yield of 1.9%, with a current payout ratio of 48.35%.

Boston Trust Walden Corp boosted its position in shares of Dolby Laboratories (NYSE:DLB - Free Report) by 2.1% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,098,218 shares of the electronics maker's stock after acquiring an additional 22,404 shares during the period. Boston Trust Walden Corp owned 1.14% of Dolby Laboratories worth $81,554,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of DLB. Bank of New York Mellon Corp lifted its position in Dolby Laboratories by 18.3% during the 1st quarter. Bank of New York Mellon Corp now owns 5,709,193 shares of the electronics maker's stock worth $458,505,000 after acquiring an additional 882,716 shares during the last quarter. Vanguard Group Inc. lifted its position in Dolby Laboratories by 7.1% during the 1st quarter. Vanguard Group Inc. now owns 7,535,722 shares of the electronics maker's stock worth $605,194,000 after acquiring an additional 502,110 shares during the last quarter. AQR Capital Management LLC raised its position in shares of Dolby Laboratories by 63.6% during the first quarter. AQR Capital Management LLC now owns 1,143,978 shares of the electronics maker's stock valued at $90,946,000 after buying an additional 444,718 shares during the last quarter. Jones Financial Companies Lllp raised its position in shares of Dolby Laboratories by 241,160.1% during the first quarter. Jones Financial Companies Lllp now owns 429,443 shares of the electronics maker's stock valued at $36,975,000 after buying an additional 429,265 shares during the last quarter. Finally, Nuveen LLC acquired a new position in shares of Dolby Laboratories during the first quarter valued at about $16,890,000. Institutional investors and hedge funds own 58.56% of the company's stock.

Dolby Laboratories Stock Up 1.0%

NYSE DLB opened at $68.80 on Tuesday. The stock has a market cap of $6.59 billion, a P/E ratio of 25.20 and a beta of 0.92. The company's 50-day simple moving average is $72.14 and its 200 day simple moving average is $73.94. Dolby Laboratories has a twelve month low of $67.83 and a twelve month high of $89.66.

Dolby Laboratories (NYSE:DLB - Get Free Report) last posted its earnings results on Thursday, July 31st. The electronics maker reported $0.78 earnings per share for the quarter, beating analysts' consensus estimates of $0.72 by $0.06. The business had revenue of $315.55 million for the quarter, compared to analysts' expectations of $305.23 million. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The firm's revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.71 earnings per share. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. Research analysts anticipate that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 20th. Shareholders of record on Tuesday, August 12th were paid a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend was Tuesday, August 12th. Dolby Laboratories's dividend payout ratio is currently 48.35%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on DLB. Rosenblatt Securities reaffirmed a "buy" rating and set a $95.00 price objective on shares of Dolby Laboratories in a research report on Friday, August 1st. Robert W. Baird began coverage on shares of Dolby Laboratories in a research report on Friday, September 5th. They set a "neutral" rating and a $74.00 price objective for the company. Baird R W raised shares of Dolby Laboratories to a "hold" rating in a research report on Friday, September 5th. Tigress Financial upped their price objective on shares of Dolby Laboratories from $112.00 to $114.00 and gave the company a "buy" rating in a research report on Friday, August 15th. Finally, Barrington Research reaffirmed an "outperform" rating and set a $100.00 price objective on shares of Dolby Laboratories in a research report on Friday, September 12th. Three analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $95.75.

Insider Activity

In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 25,000 shares of the company's stock in a transaction dated Tuesday, September 16th. The shares were sold at an average price of $71.66, for a total transaction of $1,791,500.00. Following the sale, the chief executive officer directly owned 114,725 shares of the company's stock, valued at approximately $8,221,193.50. This represents a 17.89% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Shriram Revankar sold 7,000 shares of the company's stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $74.92, for a total transaction of $524,440.00. Following the sale, the senior vice president directly owned 70,435 shares in the company, valued at $5,276,990.20. This represents a 9.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 59,491 shares of company stock worth $4,310,515 over the last ninety days. Insiders own 38.39% of the company's stock.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.